According to a survey done by www.MyBioSource.com, Rhode Islanders would pay $350 to be one of the first to receive a COVID-19 vaccine when it becomes available.

Vaccines from Pfizer and Moderna have made headlines for possibly having FDA approval by the end of this year. Some Americans have welcomed the recent news but with cautious optimism. However, just 3.7 percent of Americans will be able to receive the vaccine in 2020 according to current predictions.

Naturally, with a higher demand and less supply, many Americans will be determined to be the first in line to receive the vaccine. However, the question about how desperate they really are to get it remains.

www.MyBioSource.com, a biotechnological products distribution company, carried out a survey of 4,428 people, ages 18 and older, to find out how much each person, hypothetically, would be prepared to pay to get vaccinated ahead of others. The results revealed the average Rhode Islander would pay $350 to be first in line, compared to the nation average of $460. Those in Oklahoma would be prepared to spend $936 while residents of South Dakota would spend $279.

Participants of the survey were also worried about partaking in a vaccine that has been rushed through clinical trials. One in 5 said they are more concerned with a Coronavirus vaccine than the virus itself.

The survey also asked the participants if they would self-isolate for 14 days if they were to come into contact with someone who had coronavirus. One in 10 admitted that they would not self-isolate for the incubation period of 14 days if they suspected they had mild COVID-19 symptoms or were asymptomatic. This could be detrimental to those who are high-risk or immunocompromised.

Dr. Lisa Heiden, a spokesperson for www.MyBioSource.com said in a release, “During these unprecedented times, it is important to stay up-to-date with new medical information that is emerging on a regular basis. To reduce the risk of transmission, wear a mask when going out in public and be sure to socially distance.”